Mitochondria: The missing link between preconditioning and neuroprotection

Journal of Alzheimer's Disease

Volumn 20, Issue SUPPL.2, 2010, Pages

  Correia, Sónia C ^a,b   Santos, Renato X ^a,b   Perry, George ^c,d   Zhu, Xiongwei ^d   Moreira, Paula I ^a,e   Smith, Mark A ^d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Hypoxia inducible factor 1; mitochondria; neuroprotection; preconditioning; reactive oxygen species

Indexed keywords

CYTOCHROME C; DIAZOXIDE; HYPOXIA INDUCIBLE FACTOR 1; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; REACTIVE OXYGEN METABOLITE; UNCOUPLING PROTEIN; UNCOUPLING PROTEIN 2;

MITOCHONDRION; NERVE DEGENERATION; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

EID: 77956220265     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100669     Document Type: Review

References (118)

1. Janoff A (1964) Alterations in lysosomes (intracellular enzymes) during shock; effects of preconditioning (tolerance) and protective drugs. Int Anesthesiol Clin 2, 251-269.
2. Schurr A, Reid KH, Tseng MT, West C, Rigor BM (1986) Adaptation of adult brain tissue to anoxia and hypoxia in vitro. Brain Res 374, 244-248.
3. Kitagawa K, Matsumoto M, Kuwabara K, Tagaya M, Ohtsuki T, Hata R, Ueda H, Handa N, Kimura K, Kamada T (1991) 'Ischemic tolerance' phenomenon detected in various brain regions. Brain Res 561, 203-211.
4. Dawson VL, Dawson TM (2000) Neuronal ischaemic preconditioning. Trends Pharmacol Sci 21, 423-424.
5. Kirino T (2002) Ischemic tolerance. J Cereb Blood Flow Metab 22, 1283-1296.
6. Schaller B, Graf R (2002) Cerebral ischemic preconditioning. An experimental phenomenon or a clinical important entity of stroke prevention? J Neurol 249, 1503-1511.
7. Meller R, Minami M, Cameron JA, Impey S, Chen D, Lan JQ, Henshall DC, Simon RP (2005) CREB-mediated Bcl-2 protein expression after ischemic preconditioning. J Cereb Blood Flow Metab 25, 234-246.
8. Dirnagl U, Simon RP, Hallenbeck JM (2003) Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 26, 248-254.
9. Cadet JL, Krasnova IN (2009) Cellular and molecular neuro- biology of brain preconditioning. Mol Neurobiol 39, 50-61.
10. Gidday JM (2006) Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 7, 437-448.
11. Barone FC, White RF, Spera PA, Ellison J, Currie RW, Wang X, Feuerstein GZ (1998) Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke 29, 1937-1950; discussion 1950-11931
12. Stenzel-Poore MP, Stevens SL, King JS, Simon RP (2007) Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuropro- tective phenotypes: a speculative synthesis. Stroke 38, 680685.
13. Busija DW, Gaspar T, Domoki F, Katakam PV, Bari F (2008) Mitochondrial-mediated suppression of ROS production upon exposure of neurons to lethal stress: mitochondrial targeted preconditioning. Adv Drug Deliv Rev 60, 1471-1477.
14. Perez-Pinzon MA, Dave KR, Raval AP (2005) Role of reactive oxygen species and protein kinase C in ischemic tolerance in the brain. Antioxid Redox Signal 7, 1150-1157.
15. Duchen MR (2004) Roles of mitochondria in health and disease. Diabetes 53(Suppl 1), S96-102.
16. Dave KR, Saul I, Prado R, Busto R, Perez-Pinzon MA (2006) Remote organ ischemic preconditioning protect brain from ischemic damage following asphyxial cardiac arrest. Neurosci Lett 404, 170-175.
17. Oldenburg O, Cohen MV, Yellon DM, Downey JM (2002) Mitochondrial K(ATP) channels: role in cardioprotection. Cardiovasc Res 55, 429-437.
18. Vanden Hoek TL, Becker LB, Shao Z, Li C, Schumacker PT (1998) Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomy- ocytes. J Biol Chem 273, 18092-18098.
19. Beal MF (2005) Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58, 495-505.
20. Mattson MP, Gleichmann M, Cheng A (2008) Mitochondria in neuroplasticity and neurological disorders. Neuron 60, 748-766.
21. Green DR, Kroemer G (2004) The pathophysiology of mito- chondrial cell death. Science 305, 626-629.
22. Zhang DX, Gutterman DD (2007) Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am J Physiol Heart Circ Physiol 292, H2023-2031.
23. Dirnagl U, Meisel A (2008) Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning? Neu- ropharmacology 55, 334-344.
24. Ravati A, Ahlemeyer B, Becker A, Klumpp S, Krieglstein J (2001) Preconditioning-induced neuroprotection is mediated by reactive oxygen species and activation of the transcription factor nuclear factor-kappaB. J Neurochem 78, 909-919.
25. Ravati A, Ahlemeyer B, Becker A, Krieglstein J (2000) Preconditioning-induced neuroprotection is mediated by reactive oxygen species. Brain Res 866, 23-32.
26. Jou MJ (2008) Pathophysiological and pharmacological implications of mitochondria-targeted reactive oxygen species generation in astrocytes. Adv DrugDeliv Rev 60, 1512-1526.
27. Dirnagl U, Becker K, Meisel A (2009) Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 8, 398-412.
28. Tang XQ, Chen J, Tang EH, Feng JQ, Chen PX (2005) Hydrogen peroxide preconditioning protects PC12 cells against apoptosis induced by oxidative stress. Sheng Li Xue Bao 57, 211-216.
29. 2 in PC12 cells: mechanisms via MMP, ROS, and Bcl-2. Brain Res 1057, 57-64.
30. Furuichi T, Liu W, Shi H, Miyake M, Liu KJ (2005) Generation of hydrogen peroxide during brief oxygen-glucose deprivation induces preconditioning neuronal protection in primary cultured neurons. J Neurosci Res 79, 816-824.
31. Simerabet M, Robin E, Aristi I, Adamczyk S, Tavernier B, Vallet B, Bordet R, Lebuffe G (2008) Preconditioning by an in situ administration of hydrogen peroxide: involvement of reactive oxygen species and mitochondrial ATP-dependent potassium channel in a cerebral ischemia-reperfusion model. Brain Res 1240, 177-184.
32. Wiegand F, Liao W, Busch C, Castell S, Knapp F, Lindauer U, Megow D, Meisel A, Redetzky A, Ruscher K, Trendelenburg G, Victorov I, Riepe M, Diener HC, Dirnagl U (1999) Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J Cereb Blood Flow Metab 19, 1229-1237.
33. Horiguchi T, Kis B, Rajapakse N, Shimizu K, Busija DW (2003) Opening of mitochondrial ATP-sensitive potassium channels is a trigger of 3-nitropropionic acid-induced tolerance to transient focal cerebral ischemia in rats. Stroke 34, 1015-1020.
34. Gaspar T, Domoki F, Lenti L, Katakam PV, Snipes JA, Bari F, Busija DW (2009) Immediate neuronal preconditioning by NS1619. Brain Res 1285, 196-207.
35. Gaspar T, Snipes JA, Busija AR, Kis B, Domoki F, Bari F, Busija DW (2008) ROS-independent preconditioning in neurons via activation of mitoK(ATP) channels by BMS- 191095. J Cereb Blood Flow Metab 28, 1090-1103.
36. Bajgar R, Seetharaman S, Kowaltowski AJ, Garlid KD, Pau cek P (2001) Identification and properties of a novel intra- cellular (mitochondrial) ATP-sensitive potassium channel in brain. J Biol Chem 276, 33369-33374.
37. Debska G, May R, Kicinska A, Szewczyk A, Elger CE, Kunz WS (2001) Potassium channel openers depolarize hippocam- pal mitochondria. Brain Res 892, 42-50.
38. Kulawiak B, Bednarczyk P (2005) Reconstitution of brain mitochondria inner membrane into planar lipid bilayer. Acta Neurobiol Exp (Wars) 65, 271-276.
39. Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darb- enzio RB, D'Alonzo AJ, Lodge NJ, Smith MA, Grover GJ (1997) Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res 81, 1072-1082.
40. Szewczyk A, Wojtczak L (2002) Mitochondria as a pharmacological target. Pharmacol Rev 54, 101-127.
41. Inoue I, Nagase H, Kishi K, Higuti T (1991) ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature 352, 244-247.
42. Raval AP, Dave KR, DeFazio RA, Perez-Pinzon MA (2007) epsilonPKC phosphorylates the mitochondrial K(+) (ATP) channel during induction of ischemic preconditioning in the rat hippocampus. Brain Res 1184, 345-353.
43. Samavati L, Monick MM, Sanlioglu S, Buettner GR, Oberley LW, Hunninghake GW (2002) Mitochondrial K(ATP) channel openers activate the ERK kinase by an oxidant-dependent mechanism. Am J Physiol Cell Physiol 283, C273-281.
44. Kis B, Rajapakse NC, Snipes JA, Nagy K, Horiguchi T, Busi- ja DW (2003) Diazoxide induces delayed pre-conditioning in cultured rat cortical neurons. J Neurochem 87, 969-980.
45. Domoki F, Perciaccante JV, Veltkamp R, Bari F, Busija DW (1999) Mitochondrial potassium channel opener diazoxide preserves neuronal-vascular function after cerebral ischemia in newborn pigs. Stroke 30, 2713-2718; discussion 27182719.
46. Domoki F, Bari F, Nagy K, Busija DW, Siklos L (2004) Diazoxide prevents mitochondrial swelling and Ca2+ accumulation in CA1 pyramidal cells after cerebral ischemia in newborn pigs. Brain Res 1019, 97-104.
47. Liu D, Lu C, Wan R, Auyeung WW, Mattson MP (2002) Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release. J Cereb Blood Flow Metab 22, 431443.
48. Mayanagi K, Gaspar T, Katakam PV, Busija DW (2007) Systemic administration of diazoxide induces delayed preconditioning against transient focal cerebral ischemia in rats. Brain Res 1168, 106-111.
49. Shimizu K, Lacza Z, Rajapakse N, Horiguchi T, Snipes J, Busija DW (2002) MitoK(ATP) opener, diazoxide, reduces neuronal damage after middle cerebral artery occlusion in the rat. Am J Physiol Heart Circ Physiol 283, H1005-1011.
50. Goodman Y, Mattson MP (1996) K+ channel openers protect hippocampal neurons against oxidative injury and amyloid beta-peptide toxicity. Brain Res 706, 328-332.
51. Chi X, Sutton ET, Hellermann G, Price JM (2000) Potassium channel openers prevent beta-amyloid toxicity in bovine vascular endothelial cells. Neurosci Lett 290, 9-12.
52. Ma G, Chen S (2004) Diazoxide and N omega-nitro-L- arginine counteracted A beta 1-42-induced cytotoxicity. Neu- roreport 15, 1813-1817.
53. Ma G, Gao J, Fu Q, Jiang L, Wang R, Zhang Y, Liu K (2009) Diazoxide reverses the enhanced expression of K(ATP) sub- units in cholinergic neurons caused by exposure to Aft(1-42). Neurochem Res 34, 2133-2140.
54. Xie J, Duan L, Qian X, Huang X, Ding J, Hu G (2010) K(ATP) channel openers protect mesencephalic neurons against MPP+-induced cytotoxicity via inhibition of ROS production. J Neurosci Res 88, 428-437.
55. Yang Y, Liu X, Long Y, Wang F, Ding JH, Liu SY, Sun YH, Yao HH, Wang H, Wu J, Hu G (2006) Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats. Int J Neuropsychopharmacol 9, 51-61.
56. Tai KK, Truong DD (2002) Activation of adenosine triphosphate-sensitive potassium channels confers protection againstrotenone-inducedcell death: therapeutic implications for Parkinson's disease. J Neurosci Res 69, 559-566.
57. Tai KK, McCrossan ZA, Abbott GW (2003) Activation of mi- tochondrial ATP-sensitive potassium channels increases cell viability against rotenone-induced cell death. J Neurochem 84, 1193-1200.
58. Liu X, Wu JY, Zhou F, Sun XL, Yao HH, Yang Y, Ding JH, Hu G (2006) The regulation of rotenone-induced inflammatory factor production by ATP-sensitive potassium channel expressed in BV-2 cells. Neurosci Lett 394, 131-135.
59. Kis B, Nagy K, Snipes JA, Rajapakse NC, Horiguchi T, Grover GJ, Busija DW (2004) The mitochondrial K(ATP) channel opener BMS-191095 induces neuronal preconditioning. Neuroreport 15, 345-349.
60. Gaspar T, Katakam P, Snipes JA, Kis B, Domoki F, Bari F, Busija DW (2008) Delayed neuronal preconditioning by NS1619 is independent of calcium activated potassium channels. J Neurochem 105, 1115-1128.
61. Mayanagi K, Gaspar T, Katakam PV, Kis B, Busija DW (2007) The mitochondrial K(ATP) channel opener BMS- 191095 reduces neuronal damage after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 27,348-355.
62. Babcock DF, Hille B (1998) Mitochondrial oversight of cellular Ca2+ signaling. Curr Opin Neurobiol 8, 398-404.
63. Rizzuto R, Bernardi P, Pozzan T (2000) Mitochondria as all-round players of the calcium game. J Physiol 529(Pt 1), 37-47.
64. Nicholls DG (2002) Mitochondrial function and dysfunction in the cell: its relevance to aging and aging-related disease. Int J Biochem Cell Biol 34, 1372-1381.
65. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407, 770-776.
66. Martinou JC, Green DR (2001) Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2, 63-67.
67. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39, 44-84.
68. Raina AK, Hochman A, Zhu X, Rottkamp CA, Nunomu- ra A, Siedlak SL, Boux H, Castellani RJ, Perry G, Smith MA (2001) Abortive apoptosis in Alzheimer's disease. Acta Neuropathol (Berl) 101, 305-310.
69. Perry G, Nunomura A, Lucassen P, Lassmann H, Smith MA (1998) Apoptosis and Alzheimer's disease. Science 282, 1268-1269.
70. Zhu X, Raina AK, Perry G, Smith MA (2006) Apoptosis in Alzheimer disease: a mathematical improbability. Curr Alzheimer Res 3, 393-396.
71. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22, 391-397.
72. Fiskum G (2000) Mitochondrial participation in ischemic and traumatic neural cell death. J Neurotrauma 17, 843-855.
73. Liou AK, Clark RS, Henshall DC, Yin XM, Chen J (2003) To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog Neurobiol 69, 103142.
74. Lo EH, Dalkara T, Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4, 399415.
75. Soane L, Kahraman S, Kristian T, Fiskum G (2007) Mechanisms of impaired mitochondrial energy metabolism in acute and chronic neurodegenerative disorders. J Neurosci Res 85, 3407-3415.
76. Tsujimoto Y, Shimizu S (2007) Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 12, 835-840.
77. Schinzel AC, Takeuchi O, Huang Z, Fisher JK, Zhou Z, Rubens J, Hetz C, Danial NN, Moskowitz MA, Korsmeyer SJ (2005) Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. ProcNatl Acad Sci U SA 102, 1200512010.
78. Moreira PI, Santos MS, Moreno A, Oliveira C (2001) Amyloid beta-peptide promotes permeability transition pore in brain mitochondria. Biosci Rep 21, 789-800.
79. Moreira PI, Santos MS, Moreno A, Rego AC, Oliveira C (2002) Effect of amyloid beta-peptide on permeability transition pore: a comparative study. J Neurosci Res 69, 257-267.
80. Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, Yan Y, Wang C, Zhang H, Molkentin JD, Gunn-Moore FJ, Vonsattel JP, Arancio O, Chen JX, Yan SD (2008) Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med 14, 1097-1105.
81. Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M, Wong J, Takenouchi T, Hashimoto M, Masliah E (2000) alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 157, 401-410.
82. Song DD, Shults CW, Sisk A, Rockenstein E, Masliah E (2004) Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol 186, 158-172.
83. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM (2002) Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Car- diovasc Res 55, 534-543.
84. Javadov SA, Clarke S, Das M, Griffiths EJ, Lim KH, Halestrap AP (2003) Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol 549, 513-524.
85. Halestrap AP, Clarke SJ, Khaliulin I (2007) The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta 1767, 1007-1031.
86. Shiva S, Sack MN, Greer JJ, Duranski M, Ringwood LA, Burwell L, Wang X, MacArthur PH, Shoja A, Raghavachari N, Calvert JW, Brookes PS, Lefer DJ, Gladwin MT (2007) Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 204, 2089-2102.
87. Zhao H, Sapolsky RM, Steinberg GK (2006) Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol 34, 249-270.
88. Wu L, Shen F, Lin L, Zhang X, Bruce IC, Xia Q (2006) The neuroprotection conferred by activating the mitochondrial ATP-sensitive K+ channel is mediated by inhibiting the mi- tochondrial permeability transition pore. Neurosci Lett 402, 184-189.
89. Perez-Pinzon MA (2004) Neuroprotective effects ofischemic preconditioning in brain mitochondria following cerebral ischemia. J Bioenerg ] Biomembr 36, 323-327.
90. Dave KR, DeFazio RA, Raval AP, Torraco A, Saul I, Barri- entos A, Perez-Pinzon MA (2008) Ischemic preconditioning targets the respiration of synaptic mitochondria via protein kinase C epsilon. J Neurosci 28, 4172-4182.
91. Iijima T, Tanaka K, Matsubara S, Kawakami H, Mishima T, Suga K, Akagawa K, Iwao Y (2008) Calcium loading capacity and morphological changes in mitochondria in an ischemic preconditioned model. Neurosci Lett 448, 268-272.
92. Sack MN (2006) Mitochondrial depolarization and the role ofuncoupling proteins in ischemia tolerance. Cardiovasc Res 72, 210-219.
93. Kim-Han JS, Dugan LL (2005) Mitochondrial uncoupling proteins in the central nervous system. AntioxidRedox Signal 7, 1173-1181.
94. Duval C, Negre-Salvayre A, Dogilo A, Salvayre R, Penicaud L, Casteilla L (2002) Increased reactive oxygen species production with antisense oligonucleotides directed against uncoupling protein 2 in murine endothelial cells. Biochem Cell Biol 80, 757-764.
95. Brand MD, Esteves TC (2005) Physiological functions ofthe mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab 2, 85-93.
96. Mattiasson G, Shamloo M, Gido G, Mathi K, Tomasevic G, Yi S, Warden CH, Castilho RF, Melcher T, Gonzalez-Zulueta M, Nikolich K, Wieloch T (2003) Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat Med 9, 1062-1068.
97. Diano S, Matthews RT, Patrylo P, Yang L, Beal MF, Barn- stable CJ, Horvath TL (2003) Uncoupling protein 2 prevents neuronal death including that occurring during seizures: a mechanism for preconditioning. Endocrinology 144, 50145021.
98. Liu Y, Chen L, Xu X, Vicaut E, Sercombe R (2009) Both ischemic preconditioning and ghrelin administration protect hippocampus from ischemia/reperfusion and upregulate uncoupling protein-2. BMC Physiol 9, 17.
99. Busquets S, Alvarez B, Van Royen M, Figueras MT, Lopez- Soriano FJ, Argiles JM (2001) Increased uncoupling protein- 2 gene expression in brain of lipopolysaccharide-injected mice: role of tumour necrosis factor-alpha? Biochim Biophys Acta 1499, 249-256.
100. Echtay KS, Brand MD (2007) 4-hydroxy-2-nonenal and uncoupling proteins: an approach for regulation of mitochon- drial ROS production. Redox Rep 12, 26-29.
101. Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA (2009) Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1- uncoupling protein 2 pathway. Neuroscience 159, 993-1002.
102. Nunomura A, Honda K, Takeda A, Hirai K, Zhu X, Smith MA, Perry G (2006) Oxidative damage to RNA in neurode- generative diseases. JBiomedBiotechnol 2006, 82323.
103. Hirai K, Hayashi T, Chan PH, Zeng J, Yang GY, Basus VJ, James TL, Litt L (2004) PI3K inhibition in neonatal rat brain slices during and after hypoxia reduces phospho-Akt and increases cytosolic cytochrome c and apoptosis. Brain Res Mol Brain Res 124, 51-61.
104. Murakami K, Kondo T, Kawase M, Li Y, Sato S, Chen SF, Chan PH (1998) Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese su- peroxide dismutase deficiency. J Neurosci 18, 205-213.
105. Noshita N, Sugawara T, Fujimura M, Morita-Fujimura Y, Chan PH (2001) Manganese Superoxide Dismutase Affects Cytochrome c Release and Caspase-9 Activation After Transient Focal Cerebral Ischemia in Mice. J Cereb Blood Flow Metab 21, 557-567.
106. Scorziello A, Santillo M, Adornetto A, Dell'aversano C, Sir- abella R, Damiano S, Canzoniero LM, Renzo GF, Annunzia- to L (2007) NO-induced neuroprotection in ischemic preconditioning stimulates mitochondrial Mn-SOD activity and expression via Ras/ERK1/2 pathway. J Neurochem 103, 14721480.
107. Correia SC, Moreira PI (2010) Hypoxia-inducible factor 1: a new hope to counteract neurodegeneration? J Neurochem 112, 1-12.
108. Baranova O, Miranda LF, Pichiule P, Dragatsis I, Johnson RS, Chavez JC (2007) Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model oftransient focal cerebral ischemia. J Neurosci 27, 6320-6332.
109. Soucek T, Cumming R, Dargusch R, Maher P, Schubert D (2003) The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39, 43-56.
110. Lee DW, Rajagopalan S, Siddiq A, Gwiazda R, Yang L, Beal MF, Ratan RR, Andersen JK (2009) Inhibition of pro- lyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease. J Biol Chem 284, 29065-29076.
111. Bell EL, Klimova TA, Eisenbart J, Moraes CT, Murphy MP, Budinger GR, Chandel NS (2007) The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J Cell Biol 177, 1029-1036.
112. Brunelle JK, Bell EL, Quesada NM, Vercauteren K, Tiran- ti V, Zeviani M, Scarpulla RC, Chandel NS (2005) Oxygen sensing requires mitochondrial ROS but not oxidative phos- phorylation. Cell Metab 1, 409-414.
113. Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, Simon MC, Hammerling U, Schumacker PT (2005) Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1, 401-408.
114. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT (1998) Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl AcadSci USA 95, 11715-11720.
115. Chandel NS, McClintock DS, Feliciano CE, Wood TM, Me- lendez JA, Rodriguez AM, Schumacker PT (2000) Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem 275, 25130-25138.
116. Mansfield KD, Guzy RD, Pan Y, Young RM, Cash TP, Schumacker PT, Simon MC (2005) Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab 1, 393-399.
117. Liu J, Narasimhan P, Yu F, Chan PH (2005) Neuroprotec- tion by hypoxic preconditioning involves oxidative stress- mediated expression ofhypoxia-inducible factor and erythro- poietin. Stroke 36, 1264-1269.
118. Chang S, Jiang X, Zhao C, Lee C, Ferriero DM (2008) Exogenous low dose hydrogen peroxide increases hypoxia- inducible factor-1alpha protein expression and induces preconditioning protection against ischemia in primary cortical neurons. Neurosci Lett 441, 134-138.